Pharmaceuticals Saudi Arabia

Saudi Arabia Insomnia Treatment Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Saudi Arabia Insomnia Treatment Market Industry Trends and Forecast to 2034: Segmented by (Treatment, Type, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Saudi Arabia · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $54.7 Mn Placeholder estimate
Estimate 2025 $58.2 Mn 1.8% of the global market
Projected 2034 $100.8 Mn 73.3% Adds $42.7 Mn over 9 forecast years
CAGR 2025–2034 6.3% Faster than 15% of 180 Pharmaceuticals markets here
Key players 5
  • Saudi Arabia is 1.76% of the global market.
  • In Middle East, the largest is Saudi Arabia (this report) at $58.2 Mn.
  • Fastest growing: Saudi Arabia (this report) at 6.3% a year.
  • Saudi Arabia ranks 1st of 2 by size in Middle East.

Market size projection

Saudi Arabia

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$42.7 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Insomnia Treatment Market market size by year, Saudi Arabia
YearMarket sizeChange that yearSince 2025
2024 (estimate) $54.7 Mn — —
2025 (base) $58.2 Mn +$3.4 Mn —
2026 (forecast) $61.9 Mn +$3.7 Mn +6.3%
2027 (forecast) $65.8 Mn +$3.9 Mn +13%
2028 (forecast) $69.9 Mn +$4.1 Mn +20.1%
2029 (forecast) $74.3 Mn +$4.4 Mn +27.7%
2030 (forecast) $79.0 Mn +$4.7 Mn +35.7%
2031 (forecast) $84.0 Mn +$5.0 Mn +44.3%
2032 (forecast) $89.2 Mn +$5.3 Mn +53.4%
2033 (forecast) $94.9 Mn +$5.6 Mn +63%
2034 (forecast) $100.8 Mn +$6.0 Mn +73.3%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Saudi Arabia Insomnia Treatment Market Analysis at a glance
Market size, 2025$58.2 Mn placeholder estimate
Forecast, 2034$100.8 Mn placeholder estimate
Growth (CAGR), 2025–20346.3% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
Also calledInsomnia Therapeutics
SegmentsTreatment, type and end user (see all)
Key playersIdorsia, Merck & Co., Inc., Eisai Co., Sanofi, Big Health (see all)
Regulator in Saudi ArabiaSFDASource: Saudi Food and Drug Authority. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Saudi Arabia Insomnia Treatment Market Analysis Executive Summary

Insomnia treatment helps people fall and stay asleep with newer medicines, digital CBT for insomnia and sleep aids.

Key segments of the insomnia Treatment market include treatment (Orexin Receptor Antagonists, Z-Drugs and Melatonin Agonists) and type (Short-Term Insomnia and Chronic Insomnia).

Bar chart: Saudi Arabia Insomnia Treatment market size, 2024–2034, placeholder estimates. $54.7 Mn in 2024, $58.2 Mn in 2025 and $100.8 Mn in 2034, 6.3% CAGR.
Saudi Arabia Insomnia Treatment market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Saudi Arabia Insomnia Treatment Market Dynamics

Market Growth Drivers

More people seeking help for mental health, less stigma, better screening and new treatments with faster effects are driving the insomnia Treatment market. Governments and employers are investing more in mental health care.

Opportunity

Digital tools, new drug classes and care built into primary care and workplaces give the insomnia Treatment market strong room to grow worldwide.

Market Restraints

Shortages of mental health professionals, limited insurance coverage, side effects and the need for long-term treatment hold back the insomnia Treatment market.

Competitive Landscape for Insomnia Treatment Market in Saudi Arabia

The insomnia Treatment market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Insomnia Treatment Market in Saudi Arabia

Insomnia Treatment in Saudi Arabia: rules, payment and health figures

The Saudi Food and Drug Authority (SFDA) registers medicines before sale.⁠[1] Citizens get free public care through the Ministry of Health, while most expatriate workers must have private health insurance, regulated by the Council of Health Insurance (CHI).⁠[2] Suicide rate: 2.2 per 100,000 people in 2023, the latest WHO figure for Saudi Arabia.⁠[3]

[1] Saudi Food and Drug Authority. Checked 14 Nov 2026.

[2] Council of Health Insurance. Checked 14 Nov 2026.

[3] WHO Global Health Observatory, Suicide rate (per 100,000 people). Retrieved 15 Nov 2026.

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for insomnia Treatment. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Saudi Arabia.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Insomnia Treatment right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Insomnia Treatment in context

Saudi Arabia compared

  • Suicide rate: 2.2 per 100,000 people (2023). World: 9.2 per 100,000 people (2023). 4th highest of the 9 countries we cover in Middle East.[1]
  • Health spending per person: 1,825 US$ per person (2023). World: 1,317 US$ per person (2023). 2nd highest of the 9 countries we cover in Middle East.[2]
  • Doctors: 3.41 per 1,000 people (2023). World: 1.86 per 1,000 people (2022). Highest of the 9 countries we cover in Middle East.[3]

[1] WHO Global Health Observatory, Suicide rate (per 100,000 people). Retrieved 16 Nov 2026.

[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 16 Nov 2026.

[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 17 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Insomnia Treatment market in Saudi Arabia?
Placeholder estimate: about $58.2 Mn in 2025, rising to about $100.8 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Insomnia Treatment market in Saudi Arabia growing?
Placeholder estimate: about 6.3% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Insomnia Treatment market report cover?
The report splits the market by treatment (Orexin Receptor Antagonists, Z-Drugs, Melatonin Agonists, Digital CBT-I), type (Short-Term Insomnia, Chronic Insomnia) and end user (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies).
Who are the key players in the Insomnia Treatment market?
Key players include Idorsia, Merck & Co., Inc., Eisai Co., Sanofi and Big Health.
What is driving the Insomnia Treatment market?
More people seeking help for mental health, less stigma, better screening and new treatments with faster effects are driving the insomnia Treatment market. Governments and employers are investing more in mental health care.
Who regulates Insomnia Treatment in Saudi Arabia?
The Saudi Food and Drug Authority (SFDA) registers medicines before sale. Source: Saudi Food and Drug Authority. Checked 14 Nov 2026.
How is healthcare paid for in Saudi Arabia?
Citizens get free public care through the Ministry of Health, while most expatriate workers must have private health insurance, regulated by the Council of Health Insurance (CHI). Source: Council of Health Insurance. Checked 14 Nov 2026.
What does WHO report for Saudi Arabia?
Suicide rate: 2.2 per 100,000 people in 2023, the latest WHO figure. Source: WHO Global Health Observatory, Suicide rate (per 100,000 people). Retrieved 15 Nov 2026.
How many people in Saudi Arabia are 65 or older?
3.1% of people were 65 or older in 2025. Source: World Bank Open Data, Population ages 65 and above (% of total population), from UN population estimates. Retrieved 17 Nov 2026.
How much research is published on Insomnia Treatment?
PubMed lists 369 papers on Insomnia Treatment added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Pharmaceuticals reports in Saudi Arabia

See all

Related on sleep and mental health

See the topic